Post-approval studies (Phase 4)Study completedNCT00192140
What this trial is testing
Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age
Who this might be right for
Influenza
MedImmune LLC 345